Biologie Prospective - Santorini Conference 2004 - 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP), Santorini Island, Greece
Event Sep 30
The aims of this meeting is to bring together clinicians, laboratory medicine specialists, scientists from pharmaceutical industries, geneticists, epidemiologists for discussing how variability in the human genome could be helpful and used for:
·Prediction of risks, particularly in multifactorial diseases: cardiovascular diseases, Alzheimer, cancer…
·Evaluation of environmental risks: screening individual responses to nutrition, alcohol, tobacco, exercise and life habits.
·Pharmacogenomics: measuring the individual responses to drugs, including resistance to drugs